Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
FS Bancorp
FSBW
$323M
| $729K | ﹤0.01% |
19,176
+2
| +0% | +$78 |
|
2952
Traeger
COOK
$189M
| $728K | ﹤0.01% |
8,672
-267
| -3% | -$29.6K |
|
2953
Viemed Healthcare
VMD
$374M
| $724K | ﹤0.01% |
99,508
+15
| +0% | +$118 |
|
2954
FuelCell Energy
FCEL
$1.69B
| $724K | ﹤0.01% |
157,750
-9,568
| -6% | -$71.4K |
|
2955
ProKidney
PROK
$343M
| $723K | ﹤0.01% |
825,647
+65,860
| +9% | +$91.4K |
|
2956
Endava
DAVA
$157M
| $723K | ﹤0.01% |
37,045
+9,756
| +36% | +$271K |
|
2957
Park Aerospace
PKE
$822M
| $722K | ﹤0.01% |
53,707
+143
| +0.3% | +$2.01K |
|
|
SGMO
2958
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $720K | ﹤0.01% |
1,097,834
-41,418
| -4% | -$43.9K |
|
2959
Southern First Bancshares
SFST
$608M
| $714K | ﹤0.01% |
21,676
+106
| +0.5% | +$3.71K |
|
|
SRG
2960
Seritage Growth Properties
SRG
$139M
| $711K | ﹤0.01% |
220,205
-7,560
| -3% | -$27.7K |
|
2961
Verastem
VSTM
$511M
| $710K | ﹤0.01% |
117,784
+4,183
| +4% | +$25.6K |
|
2962
AerSale
ASLE
$308M
| $707K | ﹤0.01% |
94,344
+41
| +0% | +$293 |
|
2963
Ero Copper
ERO
$3.17B
| $706K | ﹤0.01% |
58,295
+9,810
| +20% | +$131K |
|
2964
NET Power
NPWR
$134M
| $706K | ﹤0.01% |
268,252
-7,560
| -3% | -$53.4K |
|
2965
Cricut
CRCT
$1.27B
| $703K | ﹤0.01% |
136,475
+25,330
| +23% | +$141K |
|
|
MBX
2966
MBX Biosciences
MBX
$3.21B
| $698K | ﹤0.01% |
94,546
+1,235
| +1% | +$13.1K |
|
|
ACRE
2967
Ares Commercial Real Estate
ACRE
$261M
| $695K | ﹤0.01% |
150,212
| – | – |
|
|
TBCH
2968
Turtle Beach Corp
TBCH
$276M
| $695K | ﹤0.01% |
48,686
-3,050
| -6% | -$50.8K |
|
2969
Amprius Technologies
AMPX
$1.66B
| $691K | ﹤0.01% |
257,943
+59,501
| +30% | +$176K |
|
2970
ReposiTrak
TRAK
$156M
| $690K | ﹤0.01% |
34,043
| – | – |
|
|
INR
2971
Infinity Natural Resources
INR
$239M
| $688K | ﹤0.01% |
+36,708
| New | +$688K |
|
|
SEPN
2972
Septerna Inc
SEPN
$1.75B
| $686K | ﹤0.01% |
118,451
-21,165
| -15% | -$242K |
|
2973
Brown-Forman Class A
BF.A
$13.2B
| $685K | ﹤0.01% |
20,475
-7,360
| -26% | -$247K |
|
2974
Choiceone Financial
COFS
$511M
| $682K | ﹤0.01% |
23,706
| – | – |
|
|
SION
2975
Sionna Therapeutics
SION
$2.14B
| $676K | ﹤0.01% |
+64,644
| New | +$1.06M |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.